Czechia – Medicinal products for the cardiovascular system – Léčivé přípravky s obsahem rosuvastatinu, fenofibrátu, ezetimibu, kyseliny bempedoové, sodné soli olezarsenu

The subject of the public contract is the continuous supply of medicinal products containing rosuvastatin, fenofibrate, ezetimibe, bempedoic acid, and sodium olezarsen for a period of 4 years according to the current needs of the contracting authority.